Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Tredegar Poison Pill Scenario Weighed By GAMCO Investors & Mario Gabelli

Tredegar poison pill: In an amended 13D with the SEC, Mario Gabelli’s GAMCO Investors just reported an 11.8% position in Tredegar Corporation (NYSE:TG). This marks a slight increase from the billionaire’s position last quarter, and they also attached a letter mentioning that they “remain committed to shareholder value creation,” and are neither for or against current management. Gabelli’s firm also says it will be “evaluating all options” including a proposal to be included in Tredegar’s upcoming proxy vote on the company’s poison pill policy.

Mario Gabelli

For the second quarter of the year, Tredegar posted a net income from continuing operations of $9.6 million, which is equal to $0.29 per share, and is higher than the $7.4 million results showed a year ago. The net sales of the company engaged in production of plastic films and aluminum extrusions amounted to $234.5 million, up from $215.9 million reported in the second quarter of 2013.

While GAMCO is the hedge fund with the largest stake in Tredegar, we should also mention some of Gabelli’s peers, whose funds also own shares of the company. Cliff Asness’s Aqr Capital Management holds a stake which contains almost 43,400 shares, while  Jim Simons’s Renaissance Technologies owns 22,300 shares, as reported in the latest round of 13F filings.

Below you can download the letter sent from GAMCO to A. Brent King, the general counsel and corporate secretary of  Tredegar Corporation:

GAMCO’s Letter to Tredegar Corporation

Disclosure: none

Recommended Reading:

Bill Ackman Reduces Herbalife Short by 40%, Replaces It With Long-Term Put Options

Billionaire Mario Gabelli’s Apple Warning

Hedge Fund News: David Harding, Dan Loeb & Bill Ackman’s Smarter Bet

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!